We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 97.50 | 95.00 | 100.00 | 97.50 | 97.50 | 97.50 | 5,188 | 07:36:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/6/2021 13:37 | I think this is new. | lr2 | |
18/6/2021 23:28 | Nice find LR2. Just hope the word gets around the hospitals. | digger2779 | |
18/6/2021 12:08 | I didn’t need a smartphone untill I got one! | ducatiman | |
18/6/2021 11:30 | I admit to having spoken to only one radiologist about Bleepa. She was extremely interested in Bleepa and considered it to be of value. The last time I spoke to her she was going to find out more. I've no idea if she has or not but her reaction indicated that what was in place wasn't sufficient. From what I read from Aunt Minnie and other radiology reports there is a need for improvements which might help rectify the big shortage of radiologists. | ged5 | |
18/6/2021 10:34 | Interesting Ged5 but all the potential users are already going about their day-jobs without a deficit on communications (I am in frequent contact with radiology departments of hospitals). From my research, the presumption of need originates only from Feedback, i.e not real. Real need would surely be reflected by commercial interest after all this time? Call a couple of radiology departments in hospitals and find our for yourself | ydderf | |
18/6/2021 09:49 | "Clinical users at hospitals with a Bleepa contract will be able to download the app on both Apple App Store and Google Play. The CE marked medical device is the only regulated platform on the NHSX Clinical Communications Framework that allows users to share images at a standard approved for clinical use." | ged5 | |
17/6/2021 13:31 | Yump's first law states that when not many people are interested in a share and there is a frustrating lack of progress, leading to people looking for hints of progress, then its probably the best time to buy. Yump's second law states that yump's first law only applies, when you've done your analysis of features and benefits of the product and found out that it has no significant direct competitors. But who cares anyway about anyone's apparent "cleverness" on here. | yump | |
17/6/2021 12:33 | If Occam's razor is applied, the most likely explanation is that it was considered market sensitive and taken down, but in this case there would have been an RNS by now, or it was wrong and therefore misleading and taken down......either way, the share price is eloquent ydderF's law states that when bulletin boards are focused on minutiae like how many shares were traded at what price (often a few hundred quids worth in this share) and what obscure mention it got on some obscure third party website, it is not a healthy development...... | ydderf | |
17/6/2021 12:01 | Has anyone contacted the company for an explanation? | ducatiman | |
16/6/2021 22:23 | copied for you : Bleepa contract expands to Fairfield General Hospital 14/06/21 Bleepa Uncategorised We are pleased to announce the expansion of Bleepa into the Fairfield General Hospital! Bleepa is our flagship clinical communications platform. Supporting collaboration and communication Fairfield General Hospital is part of the Pennine Acute Hospital Trust and Northern Care Alliance Group. Initially, Bleepa was contracted for the Respiratory inpatient referral pathway at the Royal Oldham Hospital and has since been expanded across 10 specialties. As a result, The Trust wants to broaden the use of Bleepa as part of its strategy for greater collaboration and communication amongst clinical staff. Therefore, Fairfield General Hospital will now introduce Bleepa as the referral management tool for its Gastrointestinal and General Surgery specialties. Thus, Fairfield will have access to Bleepa’s unique and extensive features. These include intra-Trust referral pathways, image annotation, discussion capabilities, virtual multi-disciplinary meetings, and Photo-capture. All of which will create a leading clinician experience for on-the-go care delivery. “As our relationship continues to strengthen with the Pennine Acute Hospital Trust, we are delighted to see Bleepa being rolled out to an additional hospital, as well as expansion of its use within the Royal Oldham Hospital. Bleepa is the only CE-certified clinical imaging communication tool that can deliver the necessary workflow support at the scale required, with unique digital patient file access, annotation, and flexibility to enable a swift, smooth, and efficient digital referral tool for clinicians across the hospital. As Bleepa’s reputation as the clinicians’ tool of choice gains momentum, we continually look at how we can enhance its features to streamline the patient pathway and provide the digital support our clinicians need.” Dr Tom Oakley, CEO of Feedback Medical. About Fairfield General Hospital Fairfield General Hospital is the third-largest hospital run by the Trust. It is located two miles from the centre of Bury and 10.5 miles north of Manchester. Currently, it is the only remaining hospital in Bury and is one of three primary stroke units in Greater Manchester. It is also the main site for elective surgery in the North Manchester area. Additionally, the Trust has invested £2m to improve facilities in the hospital’s accident and emergency department. The improvements include a new, dedicated Children’s A&E department, which was launched in Summer 2014. | leoboy | |
16/6/2021 20:11 | It was definitely there Pete, I saw it too, we are not going mad, lol. | ducatiman | |
16/6/2021 18:57 | Yes, does appear to have disappeared. If I go to the news section, I can find all the recent items but just not the one in question. | petekand | |
16/6/2021 17:57 | But if you go to their website Ged and search Bleepa “no results found”. | ducatiman | |
16/6/2021 17:03 | yes, have been in a while have taken profits when they had runs but at this price am behind. | victor2 | |
16/6/2021 16:37 | Looking at twitter earlier today and I noticed a link to Orcha. I hadn't realised they advise trusts about various use of Apps and they seem to be backing Bleepa. | ged5 | |
16/6/2021 16:29 | Well we know it was there just before 11:00am. Thanks Victor2! You don't post often. Are you a shareholder of FDBK and have you been in long? | ged5 | |
16/6/2021 16:10 | That’s interesting victor, thanks for the info. | ducatiman | |
16/6/2021 16:02 | Just gone back to look at link posted by petekand yesterday evening and its been taken down .maybe company shouldnt have announced it, watch out for a possible rns tomorrow. | victor2 | |
16/6/2021 13:19 | A regional rollout will do for me - if the Trust actually pays for the privilege. Eighteen months to go from one to two hospitals trialling the device doesn’t bode well for a fast resolution. Pennine rather have Tom over a barrel, particularly in view of the apparent low interest levels elsewhere. But it’s clearly good to see this news, and I’m quite pleased it’s a low key release in the circumstances. | davwal | |
16/6/2021 13:18 | Couple of events where TO is talking. | petekand | |
16/6/2021 13:18 | Occam's ad hominem razor, my ass. | lr2 | |
16/6/2021 13:04 | Things starting to look up. Nice find Pete. | digger2779 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions